Remote Monitoring Systems for Self-Managing Type 2 Diabetes: A Systematic Review

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Aim: To evaluate evidence for feasibility and impact of telemedicine and web-based telemonitoring for managing Type 2 Diabetes Mellitus Methods: MEDLINE, EMBASE, CINAHL, AMED, Cochrane and PubMed were searched using the terms: telemonitoring for type-II diabetes mellitus self-management using web-based Internet solutions. The technology used, trial design, quality of life and the Glycated haemoglobin (HbA1c) outcome measures used were extracted for systemic reviews and meta-analyses, randomised controlled trials and cohort studies.Results: 426 publications were identified; 19 publications met the criteria. Ten quasi-experiments out of which seven are pre-post test studies, one is interrupted time-series study and two is cohort study and nine randomised controlled trials (RCT). Electronic transfer of glucose results from home to hospital appears to be more feasible for healthcare delivery. Six of these studies were conducted in USA, six in South Korea, three in the United Kingdom, two in Taiwan and one in each of Spain, Poland and India. The duration of the studies varied from four weeks to eighteen months and the participants were all adults. Fifteen studies showed positive improvement in HbA1c levels. One study showed high acceptance of the technology among participants. Discussion: It remains challenging to identify evidence in the rapidly changing area of remote monitoring in diabetes care. Both the technology and its typology are complex. The optimal design of a telemedicine system is still uncertain and the impact of the real-time blood glucose transmissions is still controversial. However, this synthesis supports the use of modern technology and suggests that adoption of blood sugar monitoring is feasible, acceptable and useful. Further work is needed to provide more specific up-to-date evidence of user satisfaction, empowerment and clinical outcomes.
LanguageEnglish
Title of host publicationUnknown Host Publication
Number of pages1
Publication statusPublished - 4 Nov 2014
EventThe 7th MMU Postgraduate Research Conference 2014 'Making an Impact with Research' - Manchester Metropolitan University
Duration: 4 Nov 2014 → …

Conference

ConferenceThe 7th MMU Postgraduate Research Conference 2014 'Making an Impact with Research'
Period4/11/14 → …

Fingerprint

Type 2 Diabetes Mellitus
Technology
Telemedicine
Blood Glucose
Publications
Cohort Studies
Randomized Controlled Trials
Republic of Korea
Glycosylated Hemoglobin A
Poland
Self Care
Taiwan
PubMed
MEDLINE
Internet
Spain
Meta-Analysis
India
Quality of Life
Outcome Assessment (Health Care)

Keywords

  • Type 2 diabetes
  • self-management
  • Telemonitoring
  • Telehealth
  • telemedicine
  • Connected Health Technology
  • Blood Glucose Monitoring

Cite this

@inproceedings{12696451b14749f3b35f86f8d4c20dd2,
title = "Remote Monitoring Systems for Self-Managing Type 2 Diabetes: A Systematic Review",
abstract = "Aim: To evaluate evidence for feasibility and impact of telemedicine and web-based telemonitoring for managing Type 2 Diabetes Mellitus Methods: MEDLINE, EMBASE, CINAHL, AMED, Cochrane and PubMed were searched using the terms: telemonitoring for type-II diabetes mellitus self-management using web-based Internet solutions. The technology used, trial design, quality of life and the Glycated haemoglobin (HbA1c) outcome measures used were extracted for systemic reviews and meta-analyses, randomised controlled trials and cohort studies.Results: 426 publications were identified; 19 publications met the criteria. Ten quasi-experiments out of which seven are pre-post test studies, one is interrupted time-series study and two is cohort study and nine randomised controlled trials (RCT). Electronic transfer of glucose results from home to hospital appears to be more feasible for healthcare delivery. Six of these studies were conducted in USA, six in South Korea, three in the United Kingdom, two in Taiwan and one in each of Spain, Poland and India. The duration of the studies varied from four weeks to eighteen months and the participants were all adults. Fifteen studies showed positive improvement in HbA1c levels. One study showed high acceptance of the technology among participants. Discussion: It remains challenging to identify evidence in the rapidly changing area of remote monitoring in diabetes care. Both the technology and its typology are complex. The optimal design of a telemedicine system is still uncertain and the impact of the real-time blood glucose transmissions is still controversial. However, this synthesis supports the use of modern technology and suggests that adoption of blood sugar monitoring is feasible, acceptable and useful. Further work is needed to provide more specific up-to-date evidence of user satisfaction, empowerment and clinical outcomes.",
keywords = "Type 2 diabetes, self-management, Telemonitoring, Telehealth, telemedicine, Connected Health Technology, Blood Glucose Monitoring",
author = "Hayat Mushcab and George Kernohan and Suzanne Martin",
year = "2014",
month = "11",
day = "4",
language = "English",
booktitle = "Unknown Host Publication",

}

Mushcab, H, Kernohan, G & Martin, S 2014, Remote Monitoring Systems for Self-Managing Type 2 Diabetes: A Systematic Review. in Unknown Host Publication. The 7th MMU Postgraduate Research Conference 2014 'Making an Impact with Research', 4/11/14.

Remote Monitoring Systems for Self-Managing Type 2 Diabetes: A Systematic Review. / Mushcab, Hayat; Kernohan, George; Martin, Suzanne.

Unknown Host Publication. 2014.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

TY - GEN

T1 - Remote Monitoring Systems for Self-Managing Type 2 Diabetes: A Systematic Review

AU - Mushcab, Hayat

AU - Kernohan, George

AU - Martin, Suzanne

PY - 2014/11/4

Y1 - 2014/11/4

N2 - Aim: To evaluate evidence for feasibility and impact of telemedicine and web-based telemonitoring for managing Type 2 Diabetes Mellitus Methods: MEDLINE, EMBASE, CINAHL, AMED, Cochrane and PubMed were searched using the terms: telemonitoring for type-II diabetes mellitus self-management using web-based Internet solutions. The technology used, trial design, quality of life and the Glycated haemoglobin (HbA1c) outcome measures used were extracted for systemic reviews and meta-analyses, randomised controlled trials and cohort studies.Results: 426 publications were identified; 19 publications met the criteria. Ten quasi-experiments out of which seven are pre-post test studies, one is interrupted time-series study and two is cohort study and nine randomised controlled trials (RCT). Electronic transfer of glucose results from home to hospital appears to be more feasible for healthcare delivery. Six of these studies were conducted in USA, six in South Korea, three in the United Kingdom, two in Taiwan and one in each of Spain, Poland and India. The duration of the studies varied from four weeks to eighteen months and the participants were all adults. Fifteen studies showed positive improvement in HbA1c levels. One study showed high acceptance of the technology among participants. Discussion: It remains challenging to identify evidence in the rapidly changing area of remote monitoring in diabetes care. Both the technology and its typology are complex. The optimal design of a telemedicine system is still uncertain and the impact of the real-time blood glucose transmissions is still controversial. However, this synthesis supports the use of modern technology and suggests that adoption of blood sugar monitoring is feasible, acceptable and useful. Further work is needed to provide more specific up-to-date evidence of user satisfaction, empowerment and clinical outcomes.

AB - Aim: To evaluate evidence for feasibility and impact of telemedicine and web-based telemonitoring for managing Type 2 Diabetes Mellitus Methods: MEDLINE, EMBASE, CINAHL, AMED, Cochrane and PubMed were searched using the terms: telemonitoring for type-II diabetes mellitus self-management using web-based Internet solutions. The technology used, trial design, quality of life and the Glycated haemoglobin (HbA1c) outcome measures used were extracted for systemic reviews and meta-analyses, randomised controlled trials and cohort studies.Results: 426 publications were identified; 19 publications met the criteria. Ten quasi-experiments out of which seven are pre-post test studies, one is interrupted time-series study and two is cohort study and nine randomised controlled trials (RCT). Electronic transfer of glucose results from home to hospital appears to be more feasible for healthcare delivery. Six of these studies were conducted in USA, six in South Korea, three in the United Kingdom, two in Taiwan and one in each of Spain, Poland and India. The duration of the studies varied from four weeks to eighteen months and the participants were all adults. Fifteen studies showed positive improvement in HbA1c levels. One study showed high acceptance of the technology among participants. Discussion: It remains challenging to identify evidence in the rapidly changing area of remote monitoring in diabetes care. Both the technology and its typology are complex. The optimal design of a telemedicine system is still uncertain and the impact of the real-time blood glucose transmissions is still controversial. However, this synthesis supports the use of modern technology and suggests that adoption of blood sugar monitoring is feasible, acceptable and useful. Further work is needed to provide more specific up-to-date evidence of user satisfaction, empowerment and clinical outcomes.

KW - Type 2 diabetes

KW - self-management

KW - Telemonitoring

KW - Telehealth

KW - telemedicine

KW - Connected Health Technology

KW - Blood Glucose Monitoring

M3 - Conference contribution

BT - Unknown Host Publication

ER -